This report provides a comprehensive analysis of the global Solid-Phase Peptide Synthesis (SPPS) Service market, projecting steady growth through 2032. It examines the industry landscape by segmenting services into GMP and Non-GMP types and applications ranging from scientific research to commercial use. The study evaluates key regional dynamics across the Americas, APAC, and Europe while profiling major players like Bachem and PolyPeptide. Additionally, the research highlights critical market drivers, competitive strategies, and emerging opportunities within the evolving peptide synthesis sector.

Executive Overview

Market Definition

Solid-Phase Peptide Synthesis (SPPS): A technique for peptide synthesis defined as a process in which a peptide, anchored by its C-terminus to an insoluble polymer, is assembled through the successive addition of the protected amino acids constituting its sequence.

Global Market Forecast

The global Solid-Phase Peptide Synthesis (SPPS) Service market is projected to grow from US$ 162 million in 2025 to US$ 218 million in 2032, representing a compound annual growth rate (CAGR) of 4.5% from 2026 to 2032.

Regional Market Outlook

• United States: The market for SPPS services in the United States is expected to experience growth from 2025 through 2032.
• China: The market for SPPS services in China is projected to increase over the forecast period from 2025 to 2032.
• Europe: The European market for SPPS services is estimated to expand between 2025 and 2032.

Report Scope and Methodology

Research Scope

LPI (LP Information)'s latest research report, titled “Solid-Phase Peptide Synthesis (SPPS) Service Industry Forecast,” reviews total global SPPS service sales in 2025. The report provides a comprehensive analysis of projected sales for 2026 through 2032, broken down by region, market sector, and sub-sector. All financial analyses are provided in US$ millions.

Analytical Depth

This Insight Report provides a detailed analysis of the global SPPS service landscape, highlighting key trends regarding:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments
• M&A activity

Furthermore, the report analyzes the strategies of leading global companies, focusing on their SPPS service portfolios and capabilities, market entry strategies, market positions, and geographic footprints to understand their unique positioning in an accelerating global market.

Methodology

The study evaluates key market trends, drivers, and affecting factors shaping the global outlook. It utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs to offer a nuanced view of the current state and future trajectory of the industry. The forecast breaks down market size and opportunities by type, application, and geography.

Market Segmentation

By Type

• GMP Services
• Non-GMP Services

By Application

• Commercial
• Scientific Research
• Other

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Market Dynamics

The report presents market shares and growth opportunities across product types, applications, key players, and key regions/countries. In 2025, the two largest global companies in the sector held a significant portion of the total market revenue.

Key Players

The following companies have been profiled based on primary expert input and analysis of their market coverage, product portfolios, and market penetration:

• Bachem
• PolyPeptide
• CordenPharma
• AmbioPharm
• USV Peptides
• Thermofischer
• Bio Basic
• JPT
• Genscript
• Xinbang Pharma
• ScinoPharm
• SN Biopharm
• CBL
• Piramal Pharma
• CPC Scientific
• AnaSpec

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Solid-Phase Peptide Synthesis (SPPS) Service Market Size (2021-2032)

    • 2.1.2 Solid-Phase Peptide Synthesis (SPPS) Service Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Solid-Phase Peptide Synthesis (SPPS) Service by Country/Region (2021, 2025 & 2032)

  • 2.2 Solid-Phase Peptide Synthesis (SPPS) Service Segment by Type

    • 2.2.1 GMP Services

    • 2.2.2 Non-GMP Services

    • 2.2.3 Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Type

      • 2.2.3.1 Solid-Phase Peptide Synthesis (SPPS) Service Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.3.2 Global Solid-Phase Peptide Synthesis (SPPS) Service Market Size Market Share by Type (2021-2026)

  • 2.3 Solid-Phase Peptide Synthesis (SPPS) Service Segment by Application

    • 2.3.1 Commercial

    • 2.3.2 Scientific Research

    • 2.3.3 Other

    • 2.3.4 Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Application

      • 2.3.4.1 Solid-Phase Peptide Synthesis (SPPS) Service Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.3.4.2 Global Solid-Phase Peptide Synthesis (SPPS) Service Market Size Market Share by Application (2021-2026)

• 3 Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Player

  • 3.1 Solid-Phase Peptide Synthesis (SPPS) Service Market Size Market Share by Player

    • 3.1.1 Global Solid-Phase Peptide Synthesis (SPPS) Service Revenue by Player (2021-2026)

    • 3.1.2 Global Solid-Phase Peptide Synthesis (SPPS) Service Revenue Market Share by Player (2021-2026)

  • 3.2 Global Solid-Phase Peptide Synthesis (SPPS) Service Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Solid-Phase Peptide Synthesis (SPPS) Service by Region

  • 4.1 Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Region (2021-2026)

  • 4.2 Global Solid-Phase Peptide Synthesis (SPPS) Service Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Solid-Phase Peptide Synthesis (SPPS) Service Market Size Growth (2021-2026)

  • 4.4 APAC Solid-Phase Peptide Synthesis (SPPS) Service Market Size Growth (2021-2026)

  • 4.5 Europe Solid-Phase Peptide Synthesis (SPPS) Service Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Solid-Phase Peptide Synthesis (SPPS) Service Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Country (2021-2026)

  • 5.2 Americas Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Type (2021-2026)

  • 5.3 Americas Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Region (2021-2026)

  • 6.2 APAC Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Type (2021-2026)

  • 6.3 APAC Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Country (2021-2026)

  • 7.2 Europe Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Type (2021-2026)

  • 7.3 Europe Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Solid-Phase Peptide Synthesis (SPPS) Service by Region (2021-2026)

  • 8.2 Middle East & Africa Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Solid-Phase Peptide Synthesis (SPPS) Service Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast

  • 10.1 Global Solid-Phase Peptide Synthesis (SPPS) Service Forecast by Region (2027-2032)

    • 10.1.1 Global Solid-Phase Peptide Synthesis (SPPS) Service Forecast by Region (2027-2032)

    • 10.1.2 Americas Solid-Phase Peptide Synthesis (SPPS) Service Forecast

    • 10.1.3 APAC Solid-Phase Peptide Synthesis (SPPS) Service Forecast

    • 10.1.4 Europe Solid-Phase Peptide Synthesis (SPPS) Service Forecast

    • 10.1.5 Middle East & Africa Solid-Phase Peptide Synthesis (SPPS) Service Forecast

  • 10.2 Americas Solid-Phase Peptide Synthesis (SPPS) Service Forecast by Country (2027-2032)

    • 10.2.1 United States Market Solid-Phase Peptide Synthesis (SPPS) Service Forecast

    • 10.2.2 Canada Market Solid-Phase Peptide Synthesis (SPPS) Service Forecast

    • 10.2.3 Mexico Market Solid-Phase Peptide Synthesis (SPPS) Service Forecast

    • 10.2.4 Brazil Market Solid-Phase Peptide Synthesis (SPPS) Service Forecast

  • 10.3 APAC Solid-Phase Peptide Synthesis (SPPS) Service Forecast by Region (2027-2032)

    • 10.3.1 China Solid-Phase Peptide Synthesis (SPPS) Service Market Forecast

    • 10.3.2 Japan Market Solid-Phase Peptide Synthesis (SPPS) Service Forecast

    • 10.3.3 Korea Market Solid-Phase Peptide Synthesis (SPPS) Service Forecast

    • 10.3.4 Southeast Asia Market Solid-Phase Peptide Synthesis (SPPS) Service Forecast

    • 10.3.5 India Market Solid-Phase Peptide Synthesis (SPPS) Service Forecast

    • 10.3.6 Australia Market Solid-Phase Peptide Synthesis (SPPS) Service Forecast

  • 10.4 Europe Solid-Phase Peptide Synthesis (SPPS) Service Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Solid-Phase Peptide Synthesis (SPPS) Service Forecast

    • 10.4.2 France Market Solid-Phase Peptide Synthesis (SPPS) Service Forecast

    • 10.4.3 UK Market Solid-Phase Peptide Synthesis (SPPS) Service Forecast

    • 10.4.4 Italy Market Solid-Phase Peptide Synthesis (SPPS) Service Forecast

    • 10.4.5 Russia Market Solid-Phase Peptide Synthesis (SPPS) Service Forecast

  • 10.5 Middle East & Africa Solid-Phase Peptide Synthesis (SPPS) Service Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Solid-Phase Peptide Synthesis (SPPS) Service Forecast

    • 10.5.2 South Africa Market Solid-Phase Peptide Synthesis (SPPS) Service Forecast

    • 10.5.3 Israel Market Solid-Phase Peptide Synthesis (SPPS) Service Forecast

    • 10.5.4 Turkey Market Solid-Phase Peptide Synthesis (SPPS) Service Forecast

  • 10.6 Global Solid-Phase Peptide Synthesis (SPPS) Service Forecast by Type (2027-2032)

  • 10.7 Global Solid-Phase Peptide Synthesis (SPPS) Service Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Solid-Phase Peptide Synthesis (SPPS) Service Forecast

• 11 Key Players Analysis

  • 11.1 Bachem

    • 11.1.1 Bachem Company Information

    • 11.1.2 Bachem Solid-Phase Peptide Synthesis (SPPS) Service Product Offered

    • 11.1.3 Bachem Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 Bachem Main Business Overview

    • 11.1.5 Bachem Latest Developments

  • 11.2 PolyPeptide

    • 11.2.1 PolyPeptide Company Information

    • 11.2.2 PolyPeptide Solid-Phase Peptide Synthesis (SPPS) Service Product Offered

    • 11.2.3 PolyPeptide Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 PolyPeptide Main Business Overview

    • 11.2.5 PolyPeptide Latest Developments

  • 11.3 CordenPharma

    • 11.3.1 CordenPharma Company Information

    • 11.3.2 CordenPharma Solid-Phase Peptide Synthesis (SPPS) Service Product Offered

    • 11.3.3 CordenPharma Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 CordenPharma Main Business Overview

    • 11.3.5 CordenPharma Latest Developments

  • 11.4 AmbioPharm

    • 11.4.1 AmbioPharm Company Information

    • 11.4.2 AmbioPharm Solid-Phase Peptide Synthesis (SPPS) Service Product Offered

    • 11.4.3 AmbioPharm Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 AmbioPharm Main Business Overview

    • 11.4.5 AmbioPharm Latest Developments

  • 11.5 USV Peptides

    • 11.5.1 USV Peptides Company Information

    • 11.5.2 USV Peptides Solid-Phase Peptide Synthesis (SPPS) Service Product Offered

    • 11.5.3 USV Peptides Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 USV Peptides Main Business Overview

    • 11.5.5 USV Peptides Latest Developments

  • 11.6 Thermofischer

    • 11.6.1 Thermofischer Company Information

    • 11.6.2 Thermofischer Solid-Phase Peptide Synthesis (SPPS) Service Product Offered

    • 11.6.3 Thermofischer Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 Thermofischer Main Business Overview

    • 11.6.5 Thermofischer Latest Developments

  • 11.7 Bio Basic

    • 11.7.1 Bio Basic Company Information

    • 11.7.2 Bio Basic Solid-Phase Peptide Synthesis (SPPS) Service Product Offered

    • 11.7.3 Bio Basic Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 Bio Basic Main Business Overview

    • 11.7.5 Bio Basic Latest Developments

  • 11.8 JPT

    • 11.8.1 JPT Company Information

    • 11.8.2 JPT Solid-Phase Peptide Synthesis (SPPS) Service Product Offered

    • 11.8.3 JPT Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 JPT Main Business Overview

    • 11.8.5 JPT Latest Developments

  • 11.9 Genscript

    • 11.9.1 Genscript Company Information

    • 11.9.2 Genscript Solid-Phase Peptide Synthesis (SPPS) Service Product Offered

    • 11.9.3 Genscript Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 Genscript Main Business Overview

    • 11.9.5 Genscript Latest Developments

  • 11.10 Xinbang Pharma

    • 11.10.1 Xinbang Pharma Company Information

    • 11.10.2 Xinbang Pharma Solid-Phase Peptide Synthesis (SPPS) Service Product Offered

    • 11.10.3 Xinbang Pharma Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 Xinbang Pharma Main Business Overview

    • 11.10.5 Xinbang Pharma Latest Developments

  • 11.11 ScinoPharm

    • 11.11.1 ScinoPharm Company Information

    • 11.11.2 ScinoPharm Solid-Phase Peptide Synthesis (SPPS) Service Product Offered

    • 11.11.3 ScinoPharm Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 ScinoPharm Main Business Overview

    • 11.11.5 ScinoPharm Latest Developments

  • 11.12 SN Biopharm

    • 11.12.1 SN Biopharm Company Information

    • 11.12.2 SN Biopharm Solid-Phase Peptide Synthesis (SPPS) Service Product Offered

    • 11.12.3 SN Biopharm Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 SN Biopharm Main Business Overview

    • 11.12.5 SN Biopharm Latest Developments

  • 11.13 CBL

    • 11.13.1 CBL Company Information

    • 11.13.2 CBL Solid-Phase Peptide Synthesis (SPPS) Service Product Offered

    • 11.13.3 CBL Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 CBL Main Business Overview

    • 11.13.5 CBL Latest Developments

  • 11.14 Piramal Pharma

    • 11.14.1 Piramal Pharma Company Information

    • 11.14.2 Piramal Pharma Solid-Phase Peptide Synthesis (SPPS) Service Product Offered

    • 11.14.3 Piramal Pharma Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.14.4 Piramal Pharma Main Business Overview

    • 11.14.5 Piramal Pharma Latest Developments

  • 11.15 CPC Scientific

    • 11.15.1 CPC Scientific Company Information

    • 11.15.2 CPC Scientific Solid-Phase Peptide Synthesis (SPPS) Service Product Offered

    • 11.15.3 CPC Scientific Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.15.4 CPC Scientific Main Business Overview

    • 11.15.5 CPC Scientific Latest Developments

  • 11.16 AnaSpec

    • 11.16.1 AnaSpec Company Information

    • 11.16.2 AnaSpec Solid-Phase Peptide Synthesis (SPPS) Service Product Offered

    • 11.16.3 AnaSpec Solid-Phase Peptide Synthesis (SPPS) Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.16.4 AnaSpec Main Business Overview

    • 11.16.5 AnaSpec Latest Developments

• 12 Research Findings and Conclusion